Amylin Pharmaceuticals Executive Joins Board of SDSU College of Business

Contact: Randy Carmical, Director of Communications
(619) 594-0206 Randy.Carmical@sdsu.edu

SAN DIEGO, Monday, February 13, 2007 —Deborah Rocco, Chief Learning Officer (CLO) for Amylin Pharmaceuticals, Inc., has joined the Board of Directors at the San Diego State University College of Business Administration (CBA).

As CLO, Rocco provides overall direction for executive development and learning efforts across the company. Prior to joining Amylin, Rocco held lead positions at the field and corporate levels for several large telecommunications companies. In these positions, she was responsible for leadership and executive development, organization effectiveness, as well as operational training initiatives.

Dean of the College of Business Administration Gail Naughton said, “Deborah’s experience working with both the education and bioscience professions will be of value to our board. Her familiarity with the educational process, as well as her expertise in the field of human resources, will be of great benefit to our college.”

Prior to working in the telecommunications industry, Rocco was the Assistant Dean for Career Development & Placement at the University of Denver’s Daniels College of Business, where she established the center responsible for the placement of the school’s executive and full-time MBA students.

Rocco holds a Masters of Education in Human Resource Development form Colorado State University. She is a certified executive coach and holds a Senior Professional in Human Resources designation.

“ I am honored to join the SDSU College of Business Board and look forward to supporting Dean Naughton as she leads one of the largest, nationally recognized business schools in the country,” Rocco said.

About Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,500 employees nationwide. Further information on Amylin Pharmaceuticals is available at www.amylin.com.

About the College of Business Administration - Leadership for the Global Marketplace.
With over 6,000 students, the SDSU College of Business is one of the largest business schools in the U.S. Its programs in international business and graduate entrepreneurship are ranked among the top programs in the country by U.S. News and World Report. For more information, visit www.sdsu.edu/business.

About SDSU
San Diego State University is the oldest and largest higher education institution in the San Diego region. Since it was founded in 1897, the university has grown to offer bachelors degrees in 81 areas, master’s degrees in 73 areas and doctorates in 16 areas. SDSU’s more than 34,000 students participate in an academic curriculum distinguished by direct contact with faculty and an increasing international emphasis that prepares them for a global future. For more information, visit www.sdsu.edu.